nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Contents
|
|
|
2019 |
40 |
4 |
p. v-viii |
artikel |
2 |
Contributors
|
|
|
2019 |
40 |
4 |
p. iii-iv |
artikel |
3 |
Copyright
|
|
|
2019 |
40 |
4 |
p. ii |
artikel |
4 |
Diagnostic Tests for Latent Tuberculosis Infection
|
Haas, Michelle K. |
|
2019 |
40 |
4 |
p. 829-837 |
artikel |
5 |
Epidemiology of Tuberculosis in the United States
|
Langer, Adam J. |
|
2019 |
40 |
4 |
p. 693-702 |
artikel |
6 |
Forthcoming Issues
|
|
|
2019 |
40 |
4 |
p. ix |
artikel |
7 |
How Can the Tuberculosis Laboratory Aid in the Patient-Centered Diagnosis and Management of Tuberculosis?
|
Somoskovi, Akos |
|
2019 |
40 |
4 |
p. 741-753 |
artikel |
8 |
Management of Children with Tuberculosis
|
Khatami, Ameneh |
|
2019 |
40 |
4 |
p. 797-810 |
artikel |
9 |
New Concepts in Tuberculosis Host Defense
|
Lewinsohn, David M. |
|
2019 |
40 |
4 |
p. 703-719 |
artikel |
10 |
New Drugs for the Treatment of Tuberculosis
|
Ignatius, Elisa H. |
|
2019 |
40 |
4 |
p. 811-827 |
artikel |
11 |
Preventing Transmission of Mycobacterium Tuberculosis—A Refocused Approach
|
Nardell, Edward A. |
|
2019 |
40 |
4 |
p. 857-869 |
artikel |
12 |
The Future of Vaccines for Tuberculosis
|
Stockdale, Lisa |
|
2019 |
40 |
4 |
p. 849-856 |
artikel |
13 |
Treatment of Drug-Resistant Tuberculosis
|
Mase, Sundari R. |
|
2019 |
40 |
4 |
p. 775-795 |
artikel |
14 |
Treatment of Drug-Susceptible Tuberculosis
|
Zha, Beth Shoshana |
|
2019 |
40 |
4 |
p. 763-774 |
artikel |
15 |
Treatment of Latent Tuberculosis Infection—An Update
|
Huaman, Moises A. |
|
2019 |
40 |
4 |
p. 839-848 |
artikel |
16 |
Tuberculosis
|
Lewinsohn, David M. |
|
2019 |
40 |
4 |
p. xi |
artikel |
17 |
Tuberculosis
|
Daley, Charles L. |
|
2019 |
40 |
4 |
p. i |
artikel |
18 |
Tuberculosis and Biologic Therapies
|
Godfrey, Mark S. |
|
2019 |
40 |
4 |
p. 721-739 |
artikel |
19 |
Tuberculosis Supranational Reference Laboratories
|
Gilpin, Christopher |
|
2019 |
40 |
4 |
p. 755-762 |
artikel |